What is Persivia?
Persivia operates at the vanguard of healthcare technology, providing an AI-driven platform designed to synthesize clinical, claims, social, and operational data. By transforming fragmented information into actionable, real-time insights, the company enables healthcare providers and payers to optimize workflows and improve patient outcomes. Its market position is defined by its capacity to bridge the gap between raw data and clinical decision support, effectively serving as the intelligence backbone for large-scale health systems. The platform's ability to unify diverse data sets is a key differentiator in an industry increasingly reliant on predictive analytics and automated performance management.
How much funding has Persivia raised?
Persivia has raised a total of $122.3M across 3 funding rounds:
Series C
$15M
Debt
$350K
Other Financing Round
$107M
Series C (2019): $15M with participation from Petrichor Healthcare Capital Management
Debt (2020): $350K led by PPP
Other Financing Round (2025): $107M supported by Aldrich Capital Partners
Key Investors in Persivia
Aldrich Capital Partners
Aldrich Capital Partners is a growth equity firm that supports ambitious, founder-run companies by providing both capital and operational expertise to accelerate scaling efforts.
Petrichor Healthcare Capital Management
A specialized investment firm focused on the healthcare sector, providing strategic capital to companies that demonstrate significant potential for clinical and operational impact.
PPP
Public-Private Partnership
What's next for Persivia?
With the infusion of $107M, Persivia is well-positioned to accelerate its product roadmap and expand its market footprint. The company is expected to leverage this capital to enhance its machine learning capabilities, potentially integrating more advanced predictive modeling to address the growing demand for value-based care solutions. As the healthcare sector continues to prioritize digital transformation, Persivia's focus on streamlining complex workflows will likely remain a core driver of its long-term valuation. Future strategic initiatives will likely center on deepening its integration with existing electronic health record systems and scaling its enterprise-level deployment capabilities to meet the needs of larger, more complex health networks.
See full Persivia company page
